HomeAPS • TSE
add
Aptose Biosciences Inc
Previous close
$0.52
Day range
$0.52 - $0.55
Year range
$0.46 - $4.31
Market cap
8.72M CAD
Avg Volume
5.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.34M | -49.18% |
Net income | -7.25M | 48.67% |
Net profit margin | — | — |
Earnings per share | -0.43 | 81.06% |
EBITDA | -7.34M | 49.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.33M | -64.26% |
Total assets | 10.95M | -58.80% |
Total liabilities | 13.12M | 2.63% |
Total equity | -2.18M | — |
Shares outstanding | 18.11M | — |
Price to book | -4.33 | — |
Return on assets | -154.66% | — |
Return on capital | 12,160.60% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -7.25M | 48.67% |
Cash from operations | -5.78M | 57.21% |
Cash from investing | 2.01M | 202.50% |
Cash from financing | 4.75M | 330.62% |
Net change in cash | 984.00K | 106.85% |
Free cash flow | -3.05M | 63.69% |
About
Founded
1986
Headquarters
Website
Employees
36
